T1	Biomarker 0 27	        Immunoproteasome expression
T2	Outcome 49 67	        better prognosis
T3	Treatment 84 106	    checkpoint therapies
T4	Disease 110 118	    melanoma
T5	Gene 130 136	        PSMB8
T6	Gene 141 147	        PSMB9
T7	Treatment 155 185	    immune-checkpoint inhibitors
T8	AnalysisMethod 210 226	HLA peptidomics
T9	Cytokine 310 327	    interferon gamma
T10	Cytokine 329 337	    IFNgamma
R1	Equiv T9 T10
T11	DataSource 450 454	    TCGA
T12	DataSource 460 483	    GTEX healthy controls
T13	StatisticalAnalysis 520 538	Kaplanâ€“Meier plot
T14	ComputationalTool 545 556	CIBERSORT
T15	Outcome 600 616	    improved survival
T16	Outcome 618 660	    better response to immune-checkpoint inhibitors
T17	FactorValue 680 693	    overexpression
T18	FactorValue 695 697	    OE
T19	FactorValue 699 701	    EV
T20	CellLine 720 723	    12T
T21	CellLine 725 730	    108T
T22	CellLine 732 737	    A375
T23	CellPopulation 740 768	tumor infiltrating lymphocytes
T24	Treatment 850 868	    anti-CTLA4 therapy
T25	Treatment 870 888	    anti-PD1 therapy
T26	SupplementaryFile 950 971	Supplementary Table 1
T27	SupplementaryFile 975 998	Supplementary Table 2
T28	SupplementaryFile 1000 1018	Supplementary Fig. 1
